Since 1989, chemist Derek B. Lowe, has worked for several major pharmaceutical companies on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis, and other diseases. After receiving his PhD in chemistry from Duke University, he was awarded a Humboldt fellowship to do postdoctoral research in Germany. His columns on organic and medicinal chemistry are featured in the Royal Society of Chemistry journal Chemistry World, and he has served on the advisory board for Chemical & Engineering News. Having written daily for the popular "In the Pipeline" blog (pipeline.corante.com) for over 10 years, Lowe is also a science blog pioneer with 6,000-plus Twitter followers.